ICARES Medicus, Inc. (TPEX:6612)

Market Cap	5.17B
Revenue (ttm)	859.79M
Net Income (ttm)	103.12M
Shares Out	42.57M
EPS (ttm)	2.40
PE Ratio	50.63
Forward PE	n/a
Dividend	0.30 (0.25%)
Ex-Dividend Date	Jul 8, 2024

Volume	9,343
Average Volume	71,518
Open	121.00
Previous Close	121.50
Day's Range	121.00 - 122.00
52-Week Range	104.09 - 177.00
Beta	0.73
RSI	39.12
Earnings Date	Mar 14, 2025

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.